Daniel Darazsdi, a 25-year veteran exectuvie at Honeywell International, will be the new chief financial officer at life science firm Pharmaceutical Product Development.
Darazsdi will assume the post on Oct. 1. His most recent position at Honeywell as was CFO of finance transformation.
He replaces Linda Baddour, who resigned in April.
"Dan Darazsdi is a seasoned professional whose career portfolio includes extensive experience in business unit finance, corporate treasury and international management," said Fred Eshelman, chief executive officer of PPD (Nasdaq: PPDI). "We are delighted he is joining our organization and look forward to the addition of his strategic leadership to our executive team."
Darazsdi is a graduate of James Madison University.
